Related Experiment Video
Updated: Aug 5, 2026
10:21
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
[Genomic abnormalities in myeloproliferative neoplasms]
Hiraku Ogata1,2, Yosuke Minami2
1Division of Biochemistry, Department of Biomedical Sciences, Nihon University School of Medicine.
Summary
Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) involve genetic mutations that impact prognosis and disease progression. Understanding clonal evolution is key to developing targeted therapies for MPNs.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are characterized by driver mutations.
- These MPNs evolve through genetic alterations and clonal evolution.
- Individual mutations significantly impact prognosis, leukemic transformation, and myelofibrosis progression.
Purpose of the Study:
- To review the impact of genetic alterations and clonal evolution in MPNs.
- To highlight the need for improved risk stratification and therapeutic decision-making based on mutational profiles.
- To emphasize the importance of understanding clonal evolution for developing biology-driven therapeutic strategies.
Main Methods:
- Review of large cohort studies on MPNs.
- Analysis of the clinical impact of individual and co-occurring mutations.
- Evaluation of current mutation-integrated scoring systems and comprehensive genomic testing.
Main Results:
- Specific mutations significantly influence MPN prognosis and progression.
- Certain mutations co-occur and may amplify clinical impact.
- Mutation-integrated scoring systems aid in risk stratification.
Conclusions:
- Despite advances in genomic testing, evidence for guiding MPN treatment based on mutational profiles is limited.
- A deeper understanding of clonal evolution is essential for rational, biology-driven therapeutic strategies in MPNs.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...